At biochemical and cellular levels, there is extensive evidence to support dysregulation of LRRK2 enzymatic activity as a key event in PD, notably with coding mutations in the LRRK2 gene resulting in increased kinase activity (Alessi and Sammler, 2018). Here, LRRK2 is linked to Parkinson disease.